Trademark: 97239300
Word
OBRIZANDA
Status
Registered
Status Code
700
Status Date
Tuesday, February 28, 2023
Serial Number
97239300
Registration Number
6990729
Registration Date
Tuesday, February 28, 2023
Mark Type
4000
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, December 13, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Feb 28, 2023
Notice Of Registration Confirmation Emailed
Feb 28, 2023
Registered-Principal Register
Dec 13, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Published For Opposition
Nov 23, 2022
Notification Of Notice Of Publication E-Mailed
Nov 10, 2022
Approved For Pub - Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 5, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24